Bronchodilator combinations for COPD: real hopes or a new Pandora’s box?

Roche Nicolas, Chanez Pascal

Source: Eur Respir J 2013; 42: 1441-1445
Journal Issue: December
Disease area: Airway diseases

Full text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Roche Nicolas, Chanez Pascal. Bronchodilator combinations for COPD: real hopes or a new Pandora’s box?. Eur Respir J 2013; 42: 1441-1445

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.

Related content which might interest you:
Optimising bronchodilator therapy in COPD: Who, why and when?
Source: International Congress 2019 – Personalised medicine in COPD: Matching the patient needs with the right care
Year: 2019

The paradoxes of asthma management: time for a new approach?
Source: Eur Respir J, 50 (3) 1701103; 10.1183/13993003.01103-2017
Year: 2017

Rare pulmonary diseases and orphan drugs: where do we stand and where are we going to?
Source: Eur Respir Rev 2015; 24: 375-377
Year: 2015

COPD: Still a Cinderella?
Source: Eur Respir J 2003; 22: Suppl. 45, 67s
Year: 2003

Precision medicine in COPD: where are we and where do we need to go?
Source: Eur Respir Rev, 27 (149) 180022; 10.1183/16000617.0022-2018
Year: 2018

Inhaled therapies: can they breathe new life into asthma?
Source: International Congress 2019 – The journey towards personalized medicine in asthma: where are we now?
Year: 2019

What’s new in paediatric asthma?
Source: International Congress 2018 – Paediatric Year in Review
Year: 2018

Pharmacogenetics and asthma: false hope or new dawn?
Source: Eur Respir J 2007; 29: 1239-1245
Year: 2007

Pharmacological treatment optimisation for stable COPD: an endless story?
Source: Eur Respir J, 50 (4) 1701250; 10.1183/13993003.01250-2017
Year: 2017

Control of asthma in real life: still a valuable goal?
Source: Eur Respir Rev 2015; 24: 361-369
Year: 2015

What’s new in the epidemiology of asthma?
Source: Virtual Congress 2021 – Paediatric year in review
Year: 2021

COPD: time to improve its taxonomy?
Source: ERJ Open Res, 4 (1) 00132-2017; 10.1183/23120541.00132-2017
Year: 2018

Triple therapy (ICS/LABA/LAMA) in COPD: thinking out of the box
Source: ERJ Open Res, 5 (1) 00185-2018; 10.1183/23120541.00185-2018
Year: 2019

Breathing issues in COPD, what a physio can offer?
Source: Annual Congress 2010 - Breathing issues in COPD, what a physiotherapist can offer
Year: 2010

Introducing a new formulation of pirfenidone to reduce tablet burden for the IPF patient: Is it tolerable? Is it easy to take? What do our patients think?
Source: International Congress 2018 – Management of idiopathic interstitial pneumonias: established and new treatments
Year: 2018

The future of bronchodilation: looking for new classes of bronchodilators
Source: Eur Respir Rev, 28 (154) 190095; 10.1183/16000617.0095-2019
Year: 2019